XERS Stock-Based Compensation
Xeris Biopharma Holdings Inc · Stock-Based Compensation
XERS Stock-Based Compensation
Latest reported$28.12Mperiod ending
XERS Stock-Based Comp ($540.00K → $28.12M)
Annual stock-based compensation
High-resolution chart · PNG
XERS stock-based compensation history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 22,366,000 | |
| 18,363,000 | |
| 10,716,000 | |
| 12,160,000 | |
| 11,381,000 | |
| 8,273,000 | |
| 6,484,000 | |
| 1,728,000 | |
| 499,000 | |
| 540,000 |